Aseptically Prepared Systemic Anti-Cancer Therapy Medicines
This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs and medicines used in CIVAs.
Buyer
Mid South Essex NHS Foundation Trust
Value
£2,550,000,000
Published
13 Apr 2026
Closes
11 May 2026
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
1 Dec 2026
Contract ends
30 Nov 2034
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Dose Banded Systemic Anti-Cancer Therapy Medicines
£850,000,000
Delivery: UK · United Kingdom, UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom
Lot 2 Patient Specific Systemic Anti-Cancer Therapy Medicines
£850,000,000
Delivery: UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom
Lot 3 CIVAS (Central Intravenous Additive Service)
£850,000,000
Delivery: UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom
Lot 4 Stock Inventory Management and Supply of Compounded Systemic Anti-Cancer Therapy Medicines
£850,000,000
Delivery: UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom
Documents
Unlock document linkTender notice on Find a Tender
13 Apr 2026
Tender notice on Find a Tender
Tender notice · UK4 · Web page
Pipeline notice on Find a Tender
22 May 2025
Pipeline notice on Find a Tender
Planned procurement notice · UK1 · Web page
Preliminary market engagement notice on Find a Tender
12 Aug 2025
Preliminary market engagement notice on Find a Tender
Market engagement notice · UK2 · Web page
Contract award notice on Find a Tender
26 Oct 2026
Contract award notice on Find a Tender
Award notice · UK6 · Web page
Contains public sector information licensed under the Open Government Licence v3.0.